Business Description
Orgenesis Inc
NAICS : 325412
SIC : 2834
ISIN : US68619K2042
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -1.44 | |||||
Debt-to-Equity | -1.08 | |||||
Debt-to-EBITDA | -0.28 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -36.6 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -63.1 | |||||
3-Year EBITDA Growth Rate | 22 | |||||
3-Year EPS without NRI Growth Rate | 27 | |||||
3-Year FCF Growth Rate | 46.1 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.16 | |||||
9-Day RSI | 43.36 | |||||
14-Day RSI | 43.52 | |||||
6-1 Month Momentum % | 4.61 | |||||
12-1 Month Momentum % | -21.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.25 | |||||
Quick Ratio | 0.25 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 4.08 | |||||
Days Payable | 284.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.6 | |||||
Shareholder Yield % | -39.57 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 198.16 | |||||
Operating Margin % | 1160.86 | |||||
Net Margin % | 1108.63 | |||||
FCF Margin % | 265.74 | |||||
ROE % | -500.25 | |||||
ROA % | -118.2 | |||||
ROIC % | -140.53 | |||||
ROC (Joel Greenblatt) % | -369.98 | |||||
ROCE % | -180.36 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.48 | |||||
EV-to-EBITDA | -0.49 | |||||
EV-to-Revenue | -6.15 | |||||
EV-to-FCF | -2.32 | |||||
Earnings Yield (Greenblatt) % | -208.33 | |||||
FCF Yield % | -95.01 |